• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受血管腔内血运重建术治疗慢性肢体威胁性缺血患者的外周动脉疾病分布:来自新加坡血管质量倡议的见解

Distribution of Peripheral Arterial Disease in Patients Undergoing Endovascular Revascularization for Chronic Limb Threatening Ischaemia: Insights from the Vascular Quality Initiative in Singapore.

作者信息

Soon Shereen X Y, Patel Ankur, Chong Tze Tec, Yap Charyl J Q, Tay Hsien Ts'ung, Tay Kiang Hiong, Sivanathan Chandramohan, Tang Tjun Y

机构信息

Department of Vascular Surgery, Singapore General Hospital, Singapore.

Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.

出版信息

Vasc Specialist Int. 2021 Jun 11;37:13. doi: 10.5758/vsi.210016.

DOI:10.5758/vsi.210016
PMID:34112741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8193494/
Abstract

This study aimed to examine the distribution of lower limb atherosclerotic lesions in a multi-ethnic Asian cohort with chronic limb threatening ischemia (CLTI) from Singapore. The Society for Vascular Surgery Vascular Quality Initiative registry database was used to identify 265 CLTI patients who underwent percutaneous angioplasty between June 2019 and December 2019, of whom 171 (64.5%) were male, and the mean age was 67.9±11.0 years. The majority were diabetic (84.5%) and 145 (54.7%) had chronic kidney disease (CKD). The majority of the lower limb atherosclerotic lesions were de novo lesions (598/797, 75.0%), predominantly TransAtlantic Inter-Society Consensus II C/D (451/797, 56.6%), and were moderately to severely calcified (76.3%). The anterior tibial artery and femoral-popliteal artery were the most commonly affected vessels. The mean length of the treated lesions was 14.5±13.7 cm. There was a tendency, albeit insignificant, of multi-level disease in those who were diabetic or had CKD.

摘要

本研究旨在调查来自新加坡的患有慢性肢体威胁性缺血(CLTI)的多民族亚洲队列中下肢动脉粥样硬化病变的分布情况。利用血管外科学会血管质量改进注册数据库,确定了2019年6月至2019年12月期间接受经皮血管成形术的265例CLTI患者,其中171例(64.5%)为男性,平均年龄为67.9±11.0岁。大多数患者患有糖尿病(84.5%),145例(54.7%)患有慢性肾脏病(CKD)。大多数下肢动脉粥样硬化病变为新发病变(598/797,75.0%),主要为跨大西洋两岸社会共识II C/D级(451/797,56.6%),且有中度至重度钙化(76.3%)。胫前动脉和股腘动脉是最常受累的血管。治疗病变的平均长度为14.5±13.7厘米。糖尿病患者或患有CKD的患者存在多节段病变的趋势,尽管不显著。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cded/8193494/3b6474b9ae6a/vsi-37-13-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cded/8193494/3b6474b9ae6a/vsi-37-13-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cded/8193494/3b6474b9ae6a/vsi-37-13-f1.jpg

相似文献

1
Distribution of Peripheral Arterial Disease in Patients Undergoing Endovascular Revascularization for Chronic Limb Threatening Ischaemia: Insights from the Vascular Quality Initiative in Singapore.接受血管腔内血运重建术治疗慢性肢体威胁性缺血患者的外周动脉疾病分布:来自新加坡血管质量倡议的见解
Vasc Specialist Int. 2021 Jun 11;37:13. doi: 10.5758/vsi.210016.
2
One year clinical outcomes of Rutherford 6 chronic limb threatening ischemia patients undergoing lower limb endovascular revascularisation from Singapore.来自新加坡的接受下肢血管腔内血运重建术的卢瑟福6级慢性肢体威胁性缺血患者的一年临床结局。
CVIR Endovasc. 2022 Jul 6;5(1):32. doi: 10.1186/s42155-022-00306-1.
3
Utility of a novel high pressure non-compliant balloon for tibial atherosclerotic lesions in Asian patients with chronic limb threatening ischaemia.新型高压非顺应性球囊在亚洲慢性肢体威胁性缺血合并胫骨动脉粥样硬化病变患者中的应用。
Vasa. 2020 Oct;49(6):475-482. doi: 10.1024/0301-1526/a000888. Epub 2020 Jul 22.
4
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.慢性肢体严重缺血患者行下肢血运重建术后的生存预测。
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S120-S134.e3. doi: 10.1016/j.ejvs.2019.04.009. Epub 2019 May 28.
5
Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.初发跨大西洋跨学会共识C和D型股腘动脉疾病的血管内优先治疗策略:来自单一三级转诊中心的中期结果
Vascular. 2015 Feb;23(1):31-40. doi: 10.1177/1708538114529564. Epub 2014 Apr 2.
6
Bypass surgery or percutaneous transluminal angioplasty to treat critical lower limb ischaemia due to infrainguinal arterial occlusive disease?旁路手术或经皮腔内血管成形术治疗股下动脉闭塞性疾病所致严重下肢缺血?
Hong Kong Med J. 2009 Aug;15(4):249-54.
7
Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions.比较长段股腘动脉病变的慢性肢体缺血威胁患者腔内治疗与旁路移植手术的长期疗效。
Eur J Vasc Endovasc Surg. 2021 Feb;61(2):258-269. doi: 10.1016/j.ejvs.2020.11.009. Epub 2020 Dec 15.
8
Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.经皮血管腔内髂动脉血管成形术联合腹股沟下手术血运重建治疗慢性下肢缺血:初步结果
Vascular. 2010 Mar-Apr;18(2):71-6. doi: 10.2310/6670.2010.00007.
9
10
Antegrade vs Crossover Femoral Artery Access in the Endovascular Treatment of Isolated Below-the-Knee Lesions in Patients With Critical Limb Ischemia.顺行与交叉股动脉入路在严重肢体缺血患者膝下孤立病变血管内治疗中的应用
J Endovasc Ther. 2017 Jun;24(3):331-336. doi: 10.1177/1526602817701251. Epub 2017 Apr 5.

引用本文的文献

1
Insulin-like growth factor-2 mRNA-binding protein 2 facilitates post-ischemic angiogenesis by increasing the stability of fibroblast growth factor 2 mRNA and its protein expression.胰岛素样生长因子-2 mRNA结合蛋白2通过增加成纤维细胞生长因子2 mRNA的稳定性及其蛋白表达促进缺血后血管生成。
Heliyon. 2024 Sep 3;10(17):e37364. doi: 10.1016/j.heliyon.2024.e37364. eCollection 2024 Sep 15.
2
Consumption of different types of meat and the risk of chronic limb-threatening ischemia: the Singapore Chinese Health Study.不同类型的肉类消费与慢性肢体威胁性缺血风险:新加坡华人健康研究。
Nutr J. 2024 Sep 7;23(1):103. doi: 10.1186/s12937-024-00991-9.
3

本文引用的文献

1
The modified frailty index-11 predicts medium-term outcomes after endovascular revascularisation for chronic limb threatening ischaemia in Asian patients.改良的 frailty index-11 预测亚洲患者慢性肢体威胁性缺血血管内再血管化治疗后的中期结果。
Vascular. 2022 Feb;30(1):42-51. doi: 10.1177/1708538120988228. Epub 2021 Jan 24.
2
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.2015 年全球、区域和国家外周动脉疾病的患病率和风险因素:更新的系统评价和分析。
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4.
3
The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore - 12 Months Results of the PRISTINE Registry.
新加坡亚洲患者慢性肢体威胁性缺血时西罗莫司洗脱球囊的应用 - PRISTINE 注册研究 12 个月结果。
Cardiovasc Intervent Radiol. 2024 Jul;47(7):863-874. doi: 10.1007/s00270-024-03756-3. Epub 2024 Jun 19.
4
Comparison between intermittent claudication chronic limb-threatening ischemia in peripheral arterial disease: a retrospective multicenter cohort study.外周动脉疾病中间歇性跛行与慢性肢体威胁性缺血的比较:一项回顾性多中心队列研究。
Ann Surg Treat Res. 2024 Jun;106(6):344-353. doi: 10.4174/astr.2024.106.6.344. Epub 2024 May 30.
5
Safety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study.在韩国人群中,Passeo-18 Lux 药物涂层球囊导管在下肢腔内血管重建中的安全性和有效性:一项多中心上市后监测研究。
Korean J Radiol. 2024 Jun;25(6):565-574. doi: 10.3348/kjr.2024.0099.
6
Anatomical Distribution Patterns of Peripheral Arterial Disease According to Patient Characteristics: A Unicentral Cohort Study.根据患者特征的外周动脉疾病的解剖分布模式:一项单中心队列研究。
Vasc Health Risk Manag. 2023 Jul 17;19:447-457. doi: 10.2147/VHRM.S416967. eCollection 2023.
7
One year clinical outcomes of Rutherford 6 chronic limb threatening ischemia patients undergoing lower limb endovascular revascularisation from Singapore.来自新加坡的接受下肢血管腔内血运重建术的卢瑟福6级慢性肢体威胁性缺血患者的一年临床结局。
CVIR Endovasc. 2022 Jul 6;5(1):32. doi: 10.1186/s42155-022-00306-1.
8
Utility of sirolimus coated balloons in the peripheral vasculature - a review of the current literature.西罗莫司涂层球囊在外周血管系统中的应用——当前文献综述
CVIR Endovasc. 2022 Jun 24;5(1):29. doi: 10.1186/s42155-022-00308-z.
A Review of Distribution of Atherosclerosis in the Lower Limb Arteries of Patients With Diabetes Mellitus and Peripheral Vascular Disease.
糖尿病合并周围血管疾病患者下肢动脉粥样硬化分布的综述
Vasc Endovascular Surg. 2018 Oct;52(7):535-542. doi: 10.1177/1538574418791622. Epub 2018 Aug 1.
4
Sex-Based Assessment of Patient Presentation, Lesion Characteristics, and Treatment Modalities in Patients Undergoing Peripheral Vascular Intervention.基于性别的外周血管介入治疗患者临床表现、病变特征和治疗方式评估。
Circ Cardiovasc Interv. 2018 Jan;11(1):e005749. doi: 10.1161/CIRCINTERVENTIONS.117.005749.
5
Determination of Risk Factors and Establishment of a Prediction Model for Immediate Technical Failure during Endovascular Treatment of Femoropopliteal Occlusive Disease.股腘动脉闭塞性疾病血管内治疗术中即刻技术失败的危险因素分析及预测模型的建立
Ann Vasc Surg. 2018 Apr;48:35-44. doi: 10.1016/j.avsg.2017.09.024. Epub 2017 Dec 5.
6
Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.基于膝下动脉TASC II分类的严重肢体缺血患者腘下介入治疗的中期结果
J Endovasc Ther. 2017 Jun;24(3):321-330. doi: 10.1177/1526602817704643. Epub 2017 Apr 19.
7
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).血管外科学会下肢威胁肢体分类系统:基于伤口、缺血和足部感染(WIfI)的风险分层。
J Vasc Surg. 2014 Jan;59(1):220-34.e1-2. doi: 10.1016/j.jvs.2013.08.003. Epub 2013 Oct 12.
8
Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: insight from the REACH Registry.新加坡动脉粥样硬化血栓形成患者的危险因素概况及治疗模式:来自REACH注册研究的见解
Ann Acad Med Singap. 2008 May;37(5):365-71.